Valeant Pharmaceuticals International, Inc. (VRX)

Last Three Months

26-Feb-13 -- 25-May-13

Time Period:

Three Months
|
Year

$141.22K Net Amount

Buy:	$141.22K	$70.61
Sell:	0	--

Company Sentiment

Drug Delivery

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

24

0

0

+1

0

+2

1

+3

Two Year Chart

26-May-11 -- 25-May-13

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-13 5:23 PM View:	31-Mar-13 Grant 0	Melas Kyriazi Theo Director		Valeant Pharmaceuticals International, Inc. - VRX	0% 216.34K to 216.69K	0	0	--	--	Show Txns Hide Txns

02-Apr-13 5:32 PM View:	31-Mar-13 Grant 0	Provencio Norma Ann Director		Valeant Pharmaceuticals International, Inc. - VRX	0% 178.21K to 178.68K	0	0	--	--	Show Txns Hide Txns

02-Apr-13 5:55 PM View:	31-Mar-13 Grant 0	Farmer Ronald Harold Director		Valeant Pharmaceuticals International, Inc. - VRX	2% 20.09K to 20.42K	0	0	--	--	Show Txns Hide Txns

23-Apr-13 2:51 PM View:	20-Apr-13 Payment of Exercise 0	Schiller Howard Bradley EVP and CFO		Valeant Pharmaceuticals International, Inc. - VRX	(2%) 194.02K to 189.22K	0	0	--	--	Show Txns Hide Txns

23-Apr-13 2:23 PM View:	20-Apr-13 Grant 0	Kornwasser Laizer EVP, Company Group Chairman		Valeant Pharmaceuticals International, Inc. - VRX	100% 0 to 4.0K	$141.22K 100%	0	$70.61	--	Show Txns Hide Txns